Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
startups
4
×
abbvie
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
astrazeneca
cancer
cancer immunotherapy
clinical trials
covid-19
What
ceo
4
×
acquisitions
bio
roundup
biggest
daniel
drug
gilead
medicines
o’day
sciences
aims
albert
announced
backed
bourla
build
buy
cause
collabs
company
company’s
covid
crispr
deal
debut
drugs
dyne’s
epilepsy
future
genes
genetic
gilead’s
help
imports
introduce
ipo
links
maker
maps
Language
unset
unknown
Current search:
startups
×
ceo
×
" new york top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More